First monoclonal antibody for dogs with osteoarthritis pain approved by FDA

First monoclonal antibody for dogs with osteoarthritis pain approved by FDA

Today, the U.S. Food and Drug Administration approved Librela (bedinvetmab injection) for the control of pain associated with osteoarthritis (OA) in dogs. Librela is the first monoclonal antibody (mAb) the FDA has approved for use in dogs.

Go to full article: https://www.myvetcandy.com/clinicalupdblog/2023/5/5/first-monoclonal-antibody-for-dogs-with-osteoarthritis-pain-approved-by-fda

Disclaimer: healthcareforpets.com and its team of veterinarians and clinicians do not endorse any products, services, or recommended advice. All advice presented by our veterinarians, clinicians, tools, resources, etc is not meant to replace a regular physical exam and consultation with your primary veterinarian or other clinicians. We always encourage you to seek medical advice from your regular veterinarian.

Recent News

  • Quebec’s new regulations on pet breeding, declawing come into effect next month
  • Feb 13, 2024
  • Vets urged to cut pesticide flea treatments amid river pollution fears
  • Feb 12, 2024
  • Why longer lives for our dogs could mean longer lives for us
  • Feb 11, 2024
  • Facial recognition technology being studied as a way to identify vaccinated dogs
  • Feb 4, 2024